McCormick shares are rebounding as the market digests two closely linked catalysts from late last week: a solid fiscal Q1 2026 print with reaffirmed full-year targets, and additional detail around the planned combination with Unilever’s Foods business. After the initial reaction to the transaction pushed the stock lower, today’s move reflects a re-pricing toward the underlying earnings profile and improved clarity on deal mechanics and funding.

McCormick reported fiscal Q1 results for the period ended February 28, 2026, showing sharp headline net sales growth and a large jump in reported EPS, while reaffirming its fiscal 2026 outlook (including organic growth, adjusted operating income growth, and adjusted EPS targets). The reaffirmation matters because it signals management’s confidence in baseline demand and profitability even as investors debate the leverage and integration workload implied by the Unilever Foods transaction. (ir.mccormick.com)

McCormick and Unilever agreed to combine McCormick with Unilever’s Foods business (with certain geographic exclusions), targeting a global flavor-focused company with about $20 billion in FY2025 combined revenue and an estimated $600 million in annual cost savings. Filings and deal materials also outline the cash-and-equity consideration, including a $15.7 billion cash component supported by a committed short-dated bridge facility, which is helping investors model the financing path and near-term balance-sheet risk more precisely. (ir.mccormick.com)

Near-term trading is likely to track (1) any updates on regulatory and shareholder approval milestones, (2) commentary on deleveraging plans tied to the $15.7 billion cash payment, and (3) whether management can sustain the reaffirmed FY2026 adjusted earnings trajectory while simultaneously preparing for a complex integration. Investors will also monitor whether the promised synergy run-rate and margin profile remain intact as transaction specifics, carve-outs, and separation steps progress. (ir.mccormick.com)